4.75
-0.25(-5.00%)
Currency In USD
Address
2430 North Halsted Street
Chicago, IL 60614
United States of America
Phone
847 673 1700
Website
Sector
Healthcare
Industry
Biotechnology
Employees
7
First IPO Date
May 22, 2018
| Name | Title | Pay | Year Born |
| Mr. Andy Yoo | Chief Executive Officer, President & Director | 777,167 | 1980 |
| Mr. Seung Ik Baik | Chief Financial Officer, Secretary & Director | 110,497 | 1986 |
| Mr. Joshua Miller | Chief Accounting Officer | 0 | 1977 |
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.